GW hopes to go higher on Nasdaq
AIM-listed GW Pharmaceuticals, a £72m market capitalisation British firm that makes drugs from cannabinoids, is to list American depositary shares in the US, as the company’s London share price continues to slide.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts